GH Research (GHRS) Exchange Rate Effect (2020 - 2025)
GH Research's (GHRS) quarterly Exchange Rate Effect came in at $155000.0 in Q4 2025, up 264.89% year-on-year from $42478.1 in Q4 2024, and up 160.78% quarter-over-quarter from -$255000.0 in Q3 2025.
GH Research (GHRS) Exchange Rate Effect (2020 - 2025) Analysis & Trends
GH Research's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $155000.0 for Q4 2025.
- On a quarterly basis, Exchange Rate Effect rose 264.89% year-over-year to $155000.0 in Q4 2025; TTM through Dec 2025 was $3.2 million, a 1922.29% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 1922.29% from the prior year.
- Exchange Rate Effect rose to $155000.0 in Q4 2025 per GHRS's latest filing, from -$255000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.2 million in Q2 2025 and bottomed at -$378000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$18000.0 (2021), against an average of $150300.0.
- Across the five-year window, Exchange Rate Effect plunged 2420.0% in 2022 and jumped 9655.88% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$21000.0 in 2021, then jumped by 2585.71% to $522000.0 in 2022, then slumped by 74.9% to $131000.0 in 2023, then slumped by 171.76% to -$94000.0 in 2024, then surged by 264.89% to $155000.0 in 2025.
- Per Business Quant, the three latest GHRS Exchange Rate Effect figures stand at $155000.0 (Q4 2025), -$255000.0 (Q3 2025), and $3.2 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | 155,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 155,000.00 |
| Dec 31, 2025 | 155,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Jun 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Mar 31, 2024 | -58,000.00 |
| Mar 31, 2024 | -58,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Sep 30, 2023 | -52,000.00 |
| Sep 30, 2023 | -52,000.00 |